This study aims to evaluate the incidence of low anterior resection syndrome and quality of life after cytoreductive surgery for advanced ovarian cancer patients.
Those with newly diagnosed ovarian cancer, fallopian tube cancer and primary peritoneal carcinomatosis who plan to undergo cytoreductive surgery and secondary cytoreductive surgery after neoadjuvant chemotherapy.
Patients with PCDS or rectal and sigmoid coloni tumor invasion suspected on the preoperative image and need resection of the tumor and clinical FIGO stage IIIB or higher
ECOG performance status : 0-2
Age over 18
Patient who underwent low anterior resection in the past
Past history of gastrointestinal malignant tumor except to ovarian cancer
Patient who have colostomy
Patient who underwent radiation therapy to abdominal or pelvic cavity